Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruna Panizzutti

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
International Journal of Molecular Sciences|March 29, 2023
Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-AnalysisBruna Panizzutti, David Skvarc, Sylvia Lin, et al.
Pharmacopsychiatry|September 28, 2022
Metformin is Protective Against the Development of Mood DisordersJacqueline Lake, Chiara C Bortolasci, Amanda L Stuart, et al.
Translational Psychiatry|August 25, 2025
iPSC-derived cerebral organoids reveal mitochondrial, inflammatory and neuronal vulnerabilities in bipolar disorderDana El Soufi El Sabbagh, Alencar Kolinski Machado, Lauren Pappis, et al.
Molecular Psychiatry|June 29, 2023
Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidineSourav Khanra, Preethi Reddy, Anna Giménez-Palomo, et al.
BMC Psychiatry|April 3, 2026
An international, double-blind, randomized, placebo-controlled clinical trial of adjunctive trimetazidine to treat people with bipolar depression (the TIDE trial) protocolJee Hyun Kim, Chun Hui J Park, Preethi V Reddy, et al.
Bipolar Disorders|March 9, 2023
Use of a gene expression signature to identify trimetazidine for repurposing to treat bipolar depressionChiara C Bortolasci, Srisaiyini Kidnapillai, Briana Spolding, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
International Journal of Molecular Sciences|March 29, 2023
Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-AnalysisBruna Panizzutti, David Skvarc, Sylvia Lin, et al.
Pharmacopsychiatry|September 28, 2022
Metformin is Protective Against the Development of Mood DisordersJacqueline Lake, Chiara C Bortolasci, Amanda L Stuart, et al.
Translational Psychiatry|August 25, 2025
iPSC-derived cerebral organoids reveal mitochondrial, inflammatory and neuronal vulnerabilities in bipolar disorderDana El Soufi El Sabbagh, Alencar Kolinski Machado, Lauren Pappis, et al.
Molecular Psychiatry|June 29, 2023
Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidineSourav Khanra, Preethi Reddy, Anna Giménez-Palomo, et al.
BMC Psychiatry|April 3, 2026
An international, double-blind, randomized, placebo-controlled clinical trial of adjunctive trimetazidine to treat people with bipolar depression (the TIDE trial) protocolJee Hyun Kim, Chun Hui J Park, Preethi V Reddy, et al.
Bipolar Disorders|March 9, 2023
Use of a gene expression signature to identify trimetazidine for repurposing to treat bipolar depressionChiara C Bortolasci, Srisaiyini Kidnapillai, Briana Spolding, et al.
Pageof 4